Heinzl Matthias W, Resl Michael, Kellermair Jörg, Steinwender Clemens, Mayr Bernhard, Obereder Jana, Fellner-Färber Renate, Klammer Carmen, Hartl Stefanie, Brandner Julia, Zierer Andreas, Bernhard David, Rega-Kaun Gersina, Mader Julia K, Riedl Michaela, Stingl Harald, Stechemesser Lars, Ress Claudia, Fröhlich-Reiterer Elke, Brix Johanna M, Wascher Thomas C, Sourij Harald, Fasching Peter, Clodi Martin
Abteilung für Innere Medizin, Konventhospital Barmherzige Brüder Linz, 4020 Linz, Austria.
Clinical Research Institute for Cardiovascular and Metabolic Diseases, Medical Faculty, Johannes Kepler University Linz, 4040 Linz, Austria.
J Clin Med. 2025 May 23;14(11):3668. doi: 10.3390/jcm14113668.
The intrahospital prevalence of diabetes and prediabetes is not well known in Austria and worldwide. Screening for diabetes in hospitalised patients requires systematic glycaemic assessment via HbA1c measurement, which is not routinely performed in all patients in most hospitals. This study is the first multicentre investigation to conduct structured HbA1c screening in hospitalised adult medical patients of all ages. In this exploratory multicentre analysis, HbA1c screening was performed in 3025 consecutive patients hospitalised at three different medical departments in Upper Austria. HbA1c screening was conducted over a period of three months between October 2023 and March 2024. Patients were diagnosed with diabetes (HbA1c ≥6.5% (≥48 mmol/mol)) or prediabetes (HbA1c 5.7-6.4% (39-47 mmol/mol)) based on HbA1c values or a previous diagnosis. Dysglycaemia (diabetes or prediabetes) was identified in 1557 patients (51.5%). Diabetes was present in 840 patients (27.8%) and prediabetes in 717 patients (23.7%). A first-time diagnosis of diabetes was made in 73 patients (2.4%). The prevalence of diabetes was highest among patients aged 70-79 years (36.8% diabetes; 24.8% prediabetes). Structured HbA1c screening in 3025 consecutive hospitalised patients across three medical departments in Upper Austria revealed a diabetes prevalence of 27.8% and a prediabetes prevalence of 23.7%. Overall, dysglycaemia was present in 51.5% of hospitalised patients.
在奥地利及全球范围内，医院内糖尿病和糖尿病前期的患病率尚不明确。对住院患者进行糖尿病筛查需要通过糖化血红蛋白（HbA1c）测量进行系统的血糖评估，而大多数医院并非对所有患者都常规进行此项检查。本研究是首次针对各年龄段住院成年内科患者进行结构化HbA1c筛查的多中心调查。在这项探索性多中心分析中，对奥地利上奥地利州三个不同内科科室连续收治的3025例患者进行了HbA1c筛查。HbA1c筛查在2023年10月至2024年3月的三个月期间进行。根据HbA1c值或既往诊断，患者被诊断为糖尿病（HbA1c≥6.5%（≥48 mmol/mol））或糖尿病前期（HbA1c 5.7 - 6.4%（39 - 47 mmol/mol））。1557例患者（51.5%）被确定存在血糖异常（糖尿病或糖尿病前期）。840例患者（27.8%）患有糖尿病，717例患者（23.7%）患有糖尿病前期。73例患者（2.4%）首次被诊断为糖尿病。糖尿病患病率在70 - 79岁患者中最高（糖尿病患病率为36.8%；糖尿病前期患病率为24.8%）。对奥地利上奥地利州三个内科科室连续收治的3025例患者进行结构化HbA1c筛查发现，糖尿病患病率为27.8%，糖尿病前期患病率为23.7%。总体而言，51.5%的住院患者存在血糖异常。
